Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Portugal

Marie Skłodowska-Curie Action · Running

O2CELLS Hybrid living bioengineered hierachical constructs with self-oxygenating capability for bone engineering

Coordinator
Universidade De Aveiro, Portugal
Runs
1 May 2024 to 30 April 2026
Status
Running
EU funding
€157k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101130836

What the project is doing

In the project's own words, from its summary on CORDIS.

Tissue engineering (TE) is a multi-disciplinary field that allows the fabrication of hybrid constructs to repair, replace, or induce tissue regeneration. Cells encapsulated in 3D scaffolds have been widely employed; however, encapsulation limits the homogeneous perfusion of vital soluble factors and oxygen. This results from the failure to stabilize a vascularised network within the scaffold and can lead to reduced cell proliferation, gene expression, and extracellular matrix (ECM) deposition.

With this, O2CELLS aims to develop cutting-edge advanced devices by employing an integrative strategy with natural-based biomaterials that combine with self-oxygenating microalgae and tissue progenitor cells in original multiscale structural arrangements that will stimulate the regeneration of high-quality vascularised microtissues. For this, perinatal tissues will provide human structural proteins and stem cells with unique features that will be used for the fabrication of bioinks enriched with liquefied microcapsules (Pockets) containing the microalgae and mesenchymal cells, and endothelial cells (HUVECs).

These biomaterials hierarchical features and angiogenic and osteogenic potential will be fully characterized in vitro and in vivo. O2CELLS will combine a diversity of individually pioneering concepts that could be used in the bioengineering of distinct human tissues, both for therapies and for disease model development. This ground-breaking concept is expected to pave the way to solve one of the significant challenges faced by in vitro bioengineered constructs and devise a broad disruptive platform for tissue engineering or other biotechnology challenges.

The technology developed on O2CELLS has the potential to be exceptionally rewarding to the scientific and medical communities which are in line with Goal 3 of UN 2030 Agenda (healthy life and well-being for everyone of all ages).

Topics

Who is involved

OrganisationCityCountryRole
Universidade De AveiroAveiroPortugalCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI